AZN
AstraZeneca PLC
NYSE · Healthcare · Drug Manufacturers - General · GB
$188.47
+2.50%Forward multiples
Based on analyst estimates
- P/E forward
- 17.52x
- P/E 2026E
- 18.03x
- P/E 2027E
- 16.30x
- P/E 2028E
- 14.66x
- P/S forward
- 4.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- 26.62x
- PEG TTM
- 0.50x
- Price / book
- 5.66x
- Price / sales
- 4.70x
- Price / cash flow
- 21.92x
Enterprise value
- Enterprise value
- $318.4B
- EV / sales
- 5.12x
- EV / EBITDA
- 14.90x
- EV / EBIT
- 21.64x
- Market cap
- $292.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026